 |
 |

Racial Equity in Renal TransplantationThe Disparate Impact of HLA-Based Allocation
Robert S. Gaston, MD;
Ian Ayres, JD, PhD;
Laura G. Dooley, JD;
Arnold G. Diethelm, MD
JAMA. 1993;270(11):1352-1356.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
KIDNEY transplantation from either a living related or cadaveric donor is optimal treatment for most patients with end-stage renal disease (ESRD).1 However, due to a critical shortage of organ donors, while more than 23 000 Americans await a suitable cadaveric kidney, fewer than 8000 receive transplants each year.2,3 Approximately one third of ESRD patients in this country are African American (black), a proportion threefold greater than the representation of this racial group in the general population (12%).1 Recently, the Inspector General reported that blacks are less likely than whites to receive a transplant, with almost double the waiting time.4 Currently, cadaveric kidneys are allocated according to a federally mandated system based on quality of HLA matching. This policy is based on evidence that antigenic similarity between donor and recipient may enhance cadaveric graft survival and should be the primary factor influencing distribution.5 Gjertson and colleagues
. . . [Full Text PDF of this Article]
Author Affiliations
From the Departments of Medicine (Dr Gaston) and Surgery (Drs Gaston and Diethelm), University of Alabama at Birmingham; Stanford Law School (Dr Ayres), Palo Alto, Calif; and Valparaiso (Ind) University School of Law (Ms Dooley).
Footnotes
Reprint requests to 625 Tinsley Harrison Tower, University of Alabama at Birmingham, UAB Station, Birmingham, AL 35394 (Dr Gaston).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|